Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
45,885
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,241
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Non-small Cell Lung Cancer (NSCLC)
0
Clinical Trials
10
Meta-Analyses
0
PubMed References
📋 Sample Trials
None linked yet.
📊 Sample Meta-Analyses
CRD42022377529
Efficacy and Safety of Elemene Injection Combined with Cranial Radiotherapy for Brain Metastases from Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
According to the statistics released by the National Cancer Center in 2022, ther
CRD42020162429
Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor monotherapy for advanced epidermal growth factor receptor mutated non-small cell lung cancer: a systematic review and meta-analysis
Advanced non-small cell lung cancer (NSCLC)
CRD42019135974
Efficacy and safety of six third-generation chemotherapeutic drugs (paclitaxel, docetaxel, vinorelbine, gemcitabine, pemetrexed and nab-paclitaxel) combined with platinum in the treatment of advanced non-small cell lung cancer: a network meta-analysis
Lung cancer is one of the leading causes of cancer-related deaths worldwide, wit
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Non-small Cell Lung Cancer (NSCLC)
🏥 Names
Disease Name
Non-small Cell Lung Cancer (NSCLC)
Topic Type
disease
🔍 Raw view — every non-empty column on this row (14 fields)
name
Non-small Cell Lung Cancer (NSCLC)
topic type
disease
tcmsp disease id
570
📊 Meta-Analyses
10 · systematic reviewCRD42022377529 Efficacy and Safety of Elemene Injection Combined with Cranial Radiotherapy for
→ According to the statistics released by the Nation
CRD42020162429 Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibito
→ Advanced non-small cell lung cancer (NSCLC)
CRD42019135974 Efficacy and safety of six third-generation chemotherapeutic drugs (paclitaxel,
→ Lung cancer is one of the leading causes of cancer
CRD42020213815 Weekly versus three weeks paclitaxel-based chemotherapy regimens in the treatmen
→ The patients with malignant tumors were considered
CRD42023400730 Evidence assessment for clinical efficacy and safety of Chinese herbal injection
→ It was estimated that lung cancer is the most comm
CRD42023400730 Evidence assessment for clinical efficacy and safety of Chinese herbal injection
→ It was estimated that lung cancer is the most comm
CRD42019134892 Compound kushen injection plus platinum-based chemotherapy for stage IIIB/IV non
→ Lung cancer remains the most common cancer and the
CRD42020162177 The Effect of Zilongjin Tablets combined with chemotherapy in the treatment of n
→ In the classification of lung cancer, non-small ce
CRD42020197499 Zilongjin tablet adjunct with chemotherapy for the treatment of non-small cell l
→ Lung cancer is the foremost cause of cancer-relate
CRD42023469721 Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced l
→ According to the Global Cancer Statistics 2020 rep
How to read these connections
Each box lists records connected to the one you are viewing, and says how the connection was made. A connection shows that two records are related in the source data. It does not show that something works, is safe or should be used, and a record with many connections is not necessarily better studied or more effective.
- Study records (trials, systematic reviews, publications): the study names this subject. Registered or ongoing studies have no results here, and animal or cell research does not show an effect in people.
- Source-database links (for example herb and compound, compound and gene target): taken from the imported databases and not independently checked by us.
- Name matches (for example formula and herb, or a condition named in a study): found by matching names, so they can be wrong. Treat them as leads, not findings.